• LAST PRICE
    0.7658
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.7700/ 10
  • Ask / Lots
    0.7799/ 2
  • Open / Previous Close
    0.8300 / 0.7658
  • Day Range
    Low 0.7500
    High 0.8331
  • 52 Week Range
    Low 0.4703
    High 7.4600
  • Volume
    191,398
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.8201
TimeVolumeDRRX
09:32 ET5160.83
09:38 ET5380.8331
09:41 ET37860.811
09:50 ET103520.77
09:52 ET1230.8075
09:54 ET1000.7796
09:57 ET1000.81
10:06 ET5000.8292
10:10 ET39000.79063
10:19 ET11000.81
10:35 ET1000.819
10:37 ET10000.815
10:39 ET1000.815
10:51 ET7500.815
11:00 ET124160.82
11:02 ET2000.829
11:15 ET1000.83
11:27 ET2000.819
11:31 ET69180.8152
11:40 ET129840.8
11:44 ET6980.8003
11:49 ET40000.8006
11:56 ET2900.8099
12:18 ET64200.81
12:23 ET45000.81
12:27 ET74910.81
12:30 ET13910.81
12:32 ET1000.8099
12:34 ET3330.806601
12:38 ET23320.8031
12:43 ET130590.8198
12:48 ET15570.81505
12:50 ET2100.8125
01:08 ET1000.81
01:14 ET11250.805
01:15 ET1000.805
01:21 ET60000.800446
01:24 ET2000.8004
01:28 ET1250.80477
01:32 ET1000.805
01:51 ET226010.8
01:57 ET25000.7999
02:00 ET24090.7885
02:26 ET3000.79
02:29 ET8760.79
02:45 ET1000.79499
02:47 ET10000.795
02:49 ET1000.795
03:00 ET23000.79
03:03 ET5440.79
03:07 ET85630.778
03:09 ET37000.78
03:14 ET4990.78
03:18 ET2200.7797
03:23 ET56010.77
03:27 ET2500.769565
03:32 ET9000.7699
03:36 ET1000.7666
03:48 ET44090.7699
03:50 ET149360.7501
03:52 ET64740.76
03:54 ET1860.76
03:56 ET6650.7601
03:57 ET2460.7601
03:59 ET6400.7658
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesDRRX
DURECT Corp
23.8M
-0.7x
---
United StatesJAGX
Jaguar Health Inc
24.9M
0.0x
---
United StatesTNXP
Tonix Pharmaceuticals Holding Corp
13.7M
0.0x
---
United StatesSPRB
Spruce Biosciences Inc
30.3M
-0.6x
---
United StatesFRTX
Fresh Tracks Therapeutics Inc
5.4M
-0.7x
---
United StatesRDHL
Redhill Biopharma Ltd
13.6M
0.1x
---
As of 2024-04-15

Company Information

DURECT Corporation is a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated deoxyribonucleic acid (DNA) methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury and cancer. Larsucosterol is in clinical development for the potential treatment of alcohol-associated hepatitis, for which United States Food and Drug Administration (FDA) has granted a Fast Track Designation; metabolic dysfunction-associated steatohepatitis is also being explored. Its commercial pharmaceutical products include POSIMIR (bupivacaine solution), PERSERIS (schizophrenia) and Methydur Sustained Release Capsules (ADHD). POSIMIR (bupivacaine solution) for infiltration use, a non-opioid analgesic utilizing the SABER platform technology, is FDA-approved. Its ALZET product line consists of miniature, implantable osmotic pumps and accessories used for research in mice, rats and other laboratory animals.

Contact Information

Headquarters
10240 Bubb RoadCUPERTINO, CA, United States 95014
Phone
408-777-1417
Fax
408-777-3577

Executives

Independent Chairman of the Board
Gail Maderis
President, Chief Executive Officer, Director
James Brown
Chief Financial Officer, Company Secretary
Timothy Papp
Senior Vice President - Operations and Corporate Quality Assurance
Judy Joice
Chief Medical Officer
Norman Sussman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$23.8M
Revenue (TTM)
$8.5M
Shares Outstanding
31.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.95
EPS
$-1.12
Book Value
$0.49
P/E Ratio
-0.7x
Price/Sales (TTM)
2.8
Price/Cash Flow (TTM)
---
Operating Margin
-431.49%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.